Posted on February 26, 2015 by Noah Nemoy
On February 25, 2014, MEMOTEXT Founder and President Amos Adler was invited to give a guest lecture at the University of Toronto. This honor was fresh off the heels of MEMOTEXT’s participation at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series earlier this month. The lecture was presented to Prof. Joseph Cafazzo’s Health Informatics class.
Posted on February 12, 2015
On February 11, 2014, MEMOTEXT was one of the 5 MaRS based mHealth/digital health start-ups, invited to speak at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series: Start-Ups. MEMOTEXT Founder and President Amos Adler spoke about how MEMOTEXT’s mhealth/digital health communication platform cuts costs for all stakeholders in the healthcare system and delivers clinically proven increases to adherence.
Posted on February 9, 2015 by Noah Nemoy
The mHealth market is experiencing explosive growth and countless healthcare related apps are being developed. But simply developing an app does not make it an instant success. As the ARC 360 “2015 State Of The U.S. Health & Fitness Apps Economy” report shows, it is utility and taking user concerns into account, that makes an mHealth app successful.
Posted on February 6, 2015 by Noah Nemoy
The past year has been one of tremendous growth and new opportunities for both MEMOTEXT – one of the pioneering mHealth companies – and mHealth as a whole. The two trends that power the mHealth revolution; increased usage of mobile technology and the move towards decentralized and personalized health care, have continued unabated. While mHealth is an industry still largely in its infancy, the use of this technology will only increase as the gap between the 10% of smartphone owners using health apps and 72% of patients using mobile apps, continues to close.
Posted on February 2, 2015 by Bill Simpson
I am not a medical historian, but I would bet that if you asked one, they would identify the synthesis of Aspirin in 1897 as one of most significant moments in modern medicine. With its pain-relieving, anti-inflammatory and anti-platelet (blood thinning) properties packaged within a single tablet, Aspirin provided a safe, effective and easy treatment for a wide range of illnesses. Even today, it is listed on the World Health Organization’s List of Essential Medicines and is taken daily by millions of people for the prevention of heart attacks and strokes. Its synthesis (and the pharmaceutical revolution it helped to user in) has no doubt helped to increase our lifespan and bring about a higher quality of life.